Do Chest Compresses with Mustard or Ginger Affect Warmth Regulation in Healthy Adults? A Randomized Controlled Trial.
Journal
Evidence-based complementary and alternative medicine : eCAM
ISSN: 1741-427X
Titre abrégé: Evid Based Complement Alternat Med
Pays: United States
ID NLM: 101215021
Informations de publication
Date de publication:
2022
2022
Historique:
received:
19
10
2021
revised:
25
05
2022
accepted:
27
05
2022
entrez:
28
7
2022
pubmed:
29
7
2022
medline:
29
7
2022
Statut:
epublish
Résumé
Chest compresses with mustard (MU) or ginger (GI) are a complementary treatment option for respiratory tract infections. However, little is known about their specific thermogenic qualities. This study examines the short-term effects of MU, GI, and chest compresses with warm water only (WA) on measurable and self-perceived body warmth in healthy adults. This was a single-center, randomized controlled trial with cross-over design (WA versus MU versus GI). 18 participants (23.7 ± 3.4 years; 66.7% female) received MU, GI, and WA in a random order on three different days with a mean washout period of 13.9 days. Chest compresses were applied to the thoracic back for a maximum of 20 minutes. The primary outcome measure was skin temperature of the posterior trunk (measured by infrared thermography) immediately following removal of the compresses (t1). Secondary outcome measures included skin temperature of the posterior trunk 10 minutes later (t2) and several parameters of self-perceived warmth at t1 and t2 (assessed with the Herdecke Warmth Perception Questionnaire). Skin temperature of the posterior trunk was significantly higher with MU compared to WA and GI at t1 ( Different effects on warmth regulation were observed when ginger and mustard were applied as chest compresses. Both substances induced self-perceived warming of the posterior trunk, but measurable skin temperature increased only with MU. Further research is needed to examine the duration of these thermogenic effects and how chest compresses with ginger or mustard might be incorporated into practice to influence clinical outcomes in respiratory tract infections.
Sections du résumé
Background
UNASSIGNED
Chest compresses with mustard (MU) or ginger (GI) are a complementary treatment option for respiratory tract infections. However, little is known about their specific thermogenic qualities. This study examines the short-term effects of MU, GI, and chest compresses with warm water only (WA) on measurable and self-perceived body warmth in healthy adults.
Methods
UNASSIGNED
This was a single-center, randomized controlled trial with cross-over design (WA versus MU versus GI). 18 participants (23.7 ± 3.4 years; 66.7% female) received MU, GI, and WA in a random order on three different days with a mean washout period of 13.9 days. Chest compresses were applied to the thoracic back for a maximum of 20 minutes. The primary outcome measure was skin temperature of the posterior trunk (measured by infrared thermography) immediately following removal of the compresses (t1). Secondary outcome measures included skin temperature of the posterior trunk 10 minutes later (t2) and several parameters of self-perceived warmth at t1 and t2 (assessed with the Herdecke Warmth Perception Questionnaire).
Results
UNASSIGNED
Skin temperature of the posterior trunk was significantly higher with MU compared to WA and GI at t1 (
Conclusions
UNASSIGNED
Different effects on warmth regulation were observed when ginger and mustard were applied as chest compresses. Both substances induced self-perceived warming of the posterior trunk, but measurable skin temperature increased only with MU. Further research is needed to examine the duration of these thermogenic effects and how chest compresses with ginger or mustard might be incorporated into practice to influence clinical outcomes in respiratory tract infections.
Identifiants
pubmed: 35899230
doi: 10.1155/2022/5034572
pmc: PMC9313983
doi:
Types de publication
Journal Article
Langues
eng
Pagination
5034572Informations de copyright
Copyright © 2022 Jan Vagedes et al.
Déclaration de conflit d'intérêts
The authors declare that there are no conflicts of interest.
Références
JAMA Intern Med. 2016 Jan;176(1):21-9
pubmed: 26719947
Case Rep Med. 2012;2012:519215
pubmed: 22666267
Nutr Neurosci. 2006 Jun-Aug;9(3-4):169-78
pubmed: 17176640
Molecules. 2018 Jan 21;23(1):
pubmed: 29361740
Histol Histopathol. 2015 Jul;30(7):855-64
pubmed: 25652595
Nature. 2004 Jan 15;427(6971):260-5
pubmed: 14712238
Evid Based Complement Alternat Med. 2020 Jan 30;2020:2416582
pubmed: 32076439
Wien Klin Wochenschr. 2005 Apr;117(7-8):256-68
pubmed: 15926617
Complement Ther Med. 2022 Aug;67:102834
pubmed: 35439548
Dtsch Arztebl Int. 2012 Apr;109(15):276-81
pubmed: 22567063
J Am Acad Dermatol. 2005 Jun;52(6):1049-59
pubmed: 15928624
Antibiotics (Basel). 2021 Jan 30;10(2):
pubmed: 33573118
Am J Physiol Regul Integr Comp Physiol. 2001 Sep;281(3):R894-901
pubmed: 11507006
Glob Adv Health Med. 2013 Nov;2(6):20-31
pubmed: 24416705
Int J Behav Nutr Phys Act. 2015 Jan 24;12:4
pubmed: 25616598
Nutrients. 2020 Jan 06;12(1):
pubmed: 31935866
Br J Pharmacol. 2016 Mar;173(6):953-69
pubmed: 26603538
Biochem Pharmacol. 2007 May 15;73(10):1646-56
pubmed: 17328867
Biomed Pharmacother. 2021 Nov;143:112241
pubmed: 34649363
Complement Ther Med. 2018 Oct;40:179-184
pubmed: 30219445
Complement Ther Med. 2021 Aug;60:102736
pubmed: 34058369
J Evid Based Complementary Altern Med. 2017 Jan;22(1):166-174
pubmed: 27055821
Contact Dermatitis. 1990 Sep;23(3):189-90
pubmed: 2149323
Phys Biol. 2018 Jan 24;15(2):021001
pubmed: 29135465
Br J Pharmacol. 2012 Sep;167(1):13-22
pubmed: 22563804
Complement Ther Med. 2020 Nov;54:102537
pubmed: 33183659
Evid Based Complement Alternat Med. 2019 Feb 03;2019:5365608
pubmed: 30854009
Integr Cancer Ther. 2021 Jan-Dec;20:15347354211058449
pubmed: 34814768
Auton Neurosci. 2016 Apr;196:91-104
pubmed: 26794588
Int J Mol Sci. 2018 Jun 06;19(6):
pubmed: 29882782
Can Fam Physician. 2011 Jan;57(1):31-6
pubmed: 21322286
Complement Ther Med. 2018 Dec;41:287-294
pubmed: 30477855
J Pharm Pharmacol. 2009 Jul;61(7):961-7
pubmed: 19589240
J Nat Prod. 1994 May;57(5):658-62
pubmed: 8064299
J Ethnopharmacol. 2021 Aug 10;276:114182
pubmed: 33964360
Cell Metab. 2010 Aug 4;12(2):130-41
pubmed: 20674858
Int J Hyperthermia. 2002 Nov-Dec;18(6):563-75
pubmed: 12537755
Evid Based Complement Alternat Med. 2021 Dec 3;2021:7170736
pubmed: 34899956
Evid Based Complement Alternat Med. 2015;2015:942378
pubmed: 25861373
Cancer Chemother Pharmacol. 1999;43(4):331-5
pubmed: 10071985
J Ethnopharmacol. 2021 May 10;271:113834
pubmed: 33465439
J Clin Epidemiol. 2010 Aug;63(8):e1-37
pubmed: 20346624
Evid Based Complement Alternat Med. 2013;2013:578274
pubmed: 23762145